Filing Details

Accession Number:
0000950103-18-003630
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-03-21 18:27:51
Reporting Period:
2018-03-20
Accepted Time:
2018-03-21 18:27:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1701051 Wideopenwest Inc. WOW () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1158783 Jeffrey Marcus C/O Crestview Advisors, L.l.c.
667 Madison Avenue, 10Th Floor
New York NY 10065
Yes No No No
1559054 Crestview Advisors, L.l.c. C/O Crestview Partners
667 Madison Avenue, 10Th Floor
New York NY 10065
Yes No Yes No
1608356 P Brian Cassidy C/O Crestview Advisors, L.l.c.
667 Madison Avenue, 10Th Floor
New York NY 10065
Yes No No No
1693578 G. Daniel Kilpatrick C/O Crestview Advisors, L.l.c.
667 Madison Avenue, 10Th Floor
New York NY 10065
Yes No No No
1703027 Crestview Partners Iii Gp, L.p. C/O Crestview Partners
667 Madison Avenue, 10Th Floor
New York NY 10065
Yes No Yes No
1703151 Crestview W1 Holdings, L.p. C/O Crestview Partners
667 Madison Avenue, 10Th Floor
New York NY 10065
Yes No Yes No
1703176 Crestview W1 Te Holdings, Llc C/O Crestview Partners
667 Madison Avenue, 10Th Floor
New York NY 10065
Yes No Yes No
1703177 Crestview W1 Co-Investors, Llc C/O Crestview Partners
667 Madison Avenue, 10Th Floor
New York NY 10065
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-03-20 1,306,767 $7.15 26,144,576 No 4 P Indirect See Footnotes
Common Stock Acquisiton 2018-03-21 150,000 $7.58 26,294,576 No 4 P Indirect See Footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnotes
No 4 P Indirect See Footnotes
Footnotes
  1. Includes (i) 20,865,918 shares of Common Stock beneficially owned by Crestview W1 Holdings, L.P., (ii) 1,029,448 shares of Common Stock beneficially owned by Crestview W1 TE Holdings, LLC, (iii) 4,379,080 shares of Common Stock beneficially owned by Crestview W1 Co-Investors, LLC and (iv) 20,130 restricted shares of Common Stock granted to Jeffrey A. Marcus, Brian P. Cassidy and Daniel G. Kilpatrick under the Issuers 2017 Omnibus Incentive Plan (the "Plan") that are scheduled to vest on the date of the Issuer's regularly scheduled 2018 annual stockholder's meeting, subject to the terms of the Plan and the applicable award agreement issued thereunder (each of Messrs. Marcus, Cassidy and Kilpatrick have assigned all rights, title and interest in the restricted shares of Common Stock to Crestview Advisors, L.L.C).
  2. Crestview Partners III GP, L.P. and certain of its affiliates may be deemed to have beneficial ownership of the shares of Common Stock held by Crestview W1 Holdings, L.P., Crestview W1 TE Holdings, LLC and Crestview W1 Co-Investors, LLC (collectively, the "Crestview Funds"). Crestview Partners III GP, L.P. exercises voting and dispositive power over the shares of Common Stock held by the Crestview Funds, which decisions are made by the investment committee of Crestview Partners III GP, L.P.
  3. Jeffrey A. Marcus, Brian P. Cassidy and Daniel G. Kilpatrick are each members of the Issuer's board of directors. Each of Messrs. Marcus, Cassidy and Kilpatrick are Partners of Crestview, L.L.C. (which is the general partner of Crestview Partners III GP, L.P.) and Crestview Advisors, L.L.C., which provides investment advisory and management services to certain of the foregoing entities.
  4. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.
  5. This price is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $7.31 to $7.79, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote 5 to this Form 4.